Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.
Kump P, Wurm P, Gröchenig HP, Wenzl H, Petritsch W, Halwachs B, Wagner M, Stadlbauer V, Eherer A, Hoffmann KM, Deutschmann A, Reicht G, Reiter L, Slawitsch P, Gorkiewicz G, Högenauer C. Kump P, et al. Among authors: grochenig hp. Aliment Pharmacol Ther. 2018 Jan;47(1):67-77. doi: 10.1111/apt.14387. Epub 2017 Oct 20. Aliment Pharmacol Ther. 2018. PMID: 29052237 Free PMC article.
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
Kump PK, Gröchenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, Deutschmann A, Wenzl HH, Petritsch W, Krejs GJ, Gorkiewicz G, Högenauer C. Kump PK, et al. Among authors: grochenig hp. Inflamm Bowel Dis. 2013 Sep;19(10):2155-65. doi: 10.1097/MIB.0b013e31829ea325. Inflamm Bowel Dis. 2013. PMID: 23899544
[Recommendations for the use of faecal microbiota transplantation "stool transplantation": consensus of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society of Infectious Diseases and Tropical Medicine].
Kump PK, Krause R, Steininger C, Gröchenig HP, Moschen A, Madl C, Novacek G, Allerberger F, Högenauer C. Kump PK, et al. Among authors: grochenig hp. Z Gastroenterol. 2014 Dec;52(12):1485-92. doi: 10.1055/s-0034-1385562. Epub 2014 Dec 4. Z Gastroenterol. 2014. PMID: 25474284 German.
Vedolizumab in der Behandlung der Colitis ulcerosa und des Morbus Crohn - ein Konsensus der Arbeitsgruppe "Chronisch Entzündliche Darmerkrankungen" der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie.
Novacek G, Dejaco C, Gröchenig HP, Högenauer C, Knoflach P, Miehsler W, Moschen A, Petritsch W, Vogelsang H, Tilg H. Novacek G, et al. Among authors: grochenig hp. Z Gastroenterol. 2016 May;54(5):456-67. doi: 10.1055/s-0042-103694. Epub 2016 Mar 16. Z Gastroenterol. 2016. PMID: 26982099 German. No abstract available.
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases].
Miehsler W, Dejaco C, Gröchenig HP, Fuchssteiner H, Högenauer C, Kazemi-Shirazi L, Maier H, Mayer A, Moschen A, Reinisch W, Petritsch W, Platzer R, Steiner P, Tilg H, Vogelsang H, Wenzl H, Novacek G. Miehsler W, et al. Among authors: grochenig hp. Z Gastroenterol. 2018 Mar;56(3):275-302. doi: 10.1055/s-0044-100044. Epub 2018 Mar 12. Z Gastroenterol. 2018. PMID: 29529682 German.
Diagnostic delay in patients with inflammatory bowel disease in Austria.
Novacek G, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Vogelsang H, Dejaco C, Waldhör T; Austrian IBD Study Group (ATISG). Novacek G, et al. Among authors: grochenig hp. Wien Klin Wochenschr. 2019 Mar;131(5-6):104-112. doi: 10.1007/s00508-019-1451-3. Epub 2019 Feb 4. Wien Klin Wochenschr. 2019. PMID: 30715607
Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
Gröchenig HP, Waldhör T, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Kutschera M, Dejaco C, Vogelsang H, Novacek G; Austrian IBD Study Group (ATISG). Gröchenig HP, et al. Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1211-1219. doi: 10.1097/MEG.0000000000001533. Eur J Gastroenterol Hepatol. 2019. PMID: 31498280
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 171: A 37-year-old engineer with bolus hold-up (esophageal food impaction).
Fabian E, Gröchenig HP, Bauer PK, Eherer AJ, Gugatschka M, Binder L, Langner C, Fickert P, Krejs GJ. Fabian E, et al. Among authors: grochenig hp. Wien Klin Wochenschr. 2020 Sep;132(17-18):551-559. doi: 10.1007/s00508-020-01694-x. Wien Klin Wochenschr. 2020. PMID: 32601726 Free PMC article. No abstract available.
Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease.
Kutschera M, Waldhör T, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Peters PG, Reicht G, Moser G, Dejaco C, Vogelsang H, Primas C, Novacek G, Miehsler W; Austrian IBD Study Group. Kutschera M, et al. Among authors: grochenig hp. United European Gastroenterol J. 2021 Feb;9(1):72-81. doi: 10.1177/2050640620946874. Epub 2021 Feb 18. United European Gastroenterol J. 2021. PMID: 32723070 Free PMC article.
26 results